down arrow

Beijing Tiantan Biological Products Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000WF9
  • SHG: 600161
CNY
12.31
-0.15 (-1.2%)

Sep 23

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Beijing Tiantan Biological Products Corp. Ltd.

Why is Beijing Tiantan Biological Products Corp. Ltd. ?

1
Poor Management Efficiency with a low ROCE of 28.16%
  • The company has been able to generate a Return on Capital Employed (avg) of 28.16% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of 11.15% and Operating profit at 7.80% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 16.39% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 11.15% and Operating profit at 7.80% over the last 5 years
4
With a fall in EPS of -28.82%, the company declared Very Negative results in Jun 26
  • The company has declared negative results for the last 6 consecutive quarters
  • NET SALES(HY) At CNY 2,595.37 MM has Grown at -15.69%
  • ROCE(HY) Lowest at 6.44%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.35 times
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Tiantan Biological Products Corp. Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Beijing Tiantan Biological Products Corp. Ltd.
-35.48%
-2.10
24.76%
China Shanghai Composite
3.0%
0.22
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.15%
EBIT Growth (5y)
7.80%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.52
Tax Ratio
18.78%
Dividend Payout Ratio
36.25%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.35%
ROE (avg)
16.39%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
1.90
EV to EBIT
13.13
EV to EBITDA
10.79
EV to Capital Employed
2.07
EV to Sales
3.49
PEG Ratio
NA
Dividend Yield
1.10%
ROCE (Latest)
15.77%
ROE (Latest)
11.23%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
DIVIDEND PAYOUT RATIO(Y)

Highest at 114.29%

-21What is not working for the Company
NET SALES(HY)

At CNY 2,595.37 MM has Grown at -15.69%

ROCE(HY)

Lowest at 6.44%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.35 times

RAW MATERIAL COST(Y)

Grown by 18.72% (YoY

CASH AND EQV(HY)

Lowest at CNY 4,059.36 MM

NET PROFIT(Q)

At CNY 173.04 MM has Fallen at -28.83%

Here's what is working for Beijing Tiantan Biological Products Corp. Ltd.

Dividend Payout Ratio
Highest at 114.29%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Beijing Tiantan Biological Products Corp. Ltd.

Net Sales
At CNY 2,595.37 MM has Grown at -15.69%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Debtors Turnover Ratio
Lowest at 2.35 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Net Profit
At CNY 173.04 MM has Fallen at -28.83%
over average net sales of the previous four periods of CNY 243.14 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Cash and Eqv
Lowest at CNY 4,059.36 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 18.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading